FACE DROPS
A novel risk assessment tool to distinguish LDFP from BP was developed. This tool may help guide the prescribing of antimicrobials for Lyme disease in the setting of acute facial palsy pending confirmatory laboratory evidence in the absence of an erythema migrans skin lesion.
Authors
- Nate Jowett (ORCID: https://orcid.org/0000-0002-5242-0264)
- Sun Young Chung (ORCID: https://orcid.org/0000-0002-3381-919X)
- Yan Zhao (ORCID: https://orcid.org/0009-0007-4987-5325)
- Bart K. Chwalisz (ORCID: https://orcid.org/0000-0001-9918-1742)
- Joshua W. Joseph (ORCID: https://orcid.org/0000-0001-9704-6635)
- Brian Y. Chang (ORCID: https://orcid.org/0000-0003-3067-2353)
- Gary P. Wormser (ORCID: https://orcid.org/0000-0002-8743-0948)
- Caleb R.S. McEntire (ORCID: https://orcid.org/0000-0001-5823-6727)
- Keisha Barrera
Institutions
- Brigham and Women's Hospital (US)
- Massachusetts Eye and Ear Infirmary (US)
- Mount Auburn Hospital (US)
- Harvard University (US)
- New York Medical College (US)
- Massachusetts General Hospital (US)
- Mass General Brigham (US)
- Columbia University (US)
Publication Details
- Journal
- Neurology Clinical Practice
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1212/cpj.0000000000200476
- Citations
- 1
- Primary Topic
- Facial Nerve Paralysis Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39